Status:
COMPLETED
Neuromuscular Blockade in the Intentive Care Unit, an Observational Study.
Lead Sponsor:
French Society for Intensive Care
Conditions:
Critical Care
Mechanical Ventilation
Eligibility:
All Genders
18+ years
Brief Summary
The study Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis. (Limit: 5000 characters) Neuromuscular blocking agents (NMBAs) are drug capa...
Detailed Description
Neuromuscular blocking agents (NMBAs) are usually administered during anesthesia for endotracheal tube placement or surgical interventions. But their use is also common in the medical intensive care u...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Adult Patients hospitalized in an intensive care unit
- Patient under invasive mechanical ventilation
- Administration of at least a single dose of neuromuscular blocking agent
- Exclusion criteria :
- Administration of a single dose of Succinylcholine or Rocuronium for a rapid-sequence intubation
- Moribund patient whose life expectancy is less than 24 hours
- Patient under 18 years old
- Patient under legal guardianship.
- Pregnant women
- Patient already included previously in the study
- Absence of health insurance in France
- Neuromuscular blocking agent administered outside the ICU (i.e. in the operating room)
Exclusion
Key Trial Info
Start Date :
November 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT04028362
Start Date
November 2 2019
End Date
April 1 2020
Last Update
December 16 2021
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
CH d'Argenteuil
Argenteuil, France, 95100
2
CHD Les Oudairies
La Roche-sur-Yon, France, 85925
3
CH de Versailles
Le Chesnay, France, 78157
4
CHU Kremlin-Bicetre
Le Kremlin-Bicêtre, France, 94270